Laboratory Medicine and Quality Assurance

Table. 5.

Distribution of instruments and mean, SD, and CVs (%) for glucose point-of-care testing (GGP-19-01 to GGP-19-03)

Manufacturer Instrument group No. GGP-19-01 GGP-19-02 GGP-19-03



Mean±SD CV (%) Mean±SD CV (%) Mean±SD CV (%)
Abbott Freestyle Optimum 38 72.8±2.4 3.3 146.3±2.8 1.9 309.6±11.5 3.7
Freestyle Optimum Neo 33 62.9±5.9 8.9 146.9±8.2 5.6 309.8±15.0 4.9
Freestyle Optimum Neo H 8
Freestyle Optimum Xceed 19 71.8±2.9 4.1 152.2±4.1 2.7 306.2±13.0 4.2
Allmedicus GlucoDr. Auto (AGM-4000) 10 32.6±3.8 11.7 96.9±8.0 8.2 276.0±14.9 5.4
GlucoDr. Plus (AGM-3000/B) 26 41.2±3.0 7.4 109.4±6.7 6.1 260.5±10.6 4.1
GlucoDr. (AGM-2100) 1
Others 30 36.6±2.2 5.9 98.0±4.8 4.9 278.9±16.8 6.0
Arkray Inc. Glucocard 01 10 37.1±0.9 2.4 94.3±1.4 1.5 281.5±2.5 0.9
Glucocard Ⅱ 1
Ascensia Breeze 2
Contour plus 58 52.8±1.9 3.6 115.6±3.2 2.8 274.4±9.2 3.4
Contour T 14 49.0±7.1 14.5 102.7±20.1 19.5 285.9±34.7 12.1
GC Medis Green check
Others
Infopia GlucoLAB 20 51.0±2.1 4.1 122.0±4.1 3.3 314.2±12.4 3.9
GlucoLAB Auto-coding 23 51.5±3.1 6.1 119.3±3.5 3.0 301.8±7.5 2.5
Gluneo Lite
Gluneo Plus 165 51.2±4.1 7.9 94.5±7.2 7.6 237.0±7.5 3.2
Mirae 3.3G+ 5
Others
i-SENS ACURA plus 48 40.5±3.5 8.7 111.5±5.9 5.3 301.2±17.7 5.9
BAROZen 59 39.8±3.7 9.2 107.2±7.4 6.9 288.0±21.8 7.6
BAROZen H 93 39.2±1.4 3.7 113.2±3.4 3.0 306.7±3.2 1.0
BAROzen H expert 442 51.7±2.7 5.2 113.3±6.2 5.5 319.6±12.3 3.8
BAROzen H expert plus 203 51.6±2.2 4.2 113.1±3.3 2.9 318.3±7.6 2.4
BAROZen H plus 170 50.3±3.1 6.8 110.9±10.3 9.3 314.6±43.8 13.9
BAROZen II 10 39.0±0.9 2.2 105.8±0.7 0.6 298.8±7.3 2.4
BAROZen plus 67 48.4±2.5 5.2 99.1±2.6 2.6 267.1±6.2 6.3
CareSens Dual 10 114.1±2.9 2.5 416.2±10.7 2.6
CareSens II 11 32.5±3.8 11.7 98.6±6.8 6.9 284.0±43.0 15.1
CareSens N 61 42.6±3.8 8.8 114.4±7.4 6.5 318.2±14.1 4.4
CareSens N Voice 113 35.3±2.1 5.9 107.1±5.7 5.3 300.6±19.4 6.4
CareSens PRO 107 49.3±3.4 6.9 114.9±5.0 4.4 370.3±33.5 9.1
others
Philosys Gmate check 46 48.7±3.7 7.7 121.8±4.3 3.5 332.9±22.3 6.7
Gmate Origin 28 61.6±3.4 5.5 135.4±3.9 2.9 340.0±6.8 2.0
Gmate WHeeL 11 55.4±1.3 2.3 124.4±1.6 1.3 324.5±1.8 0.5
Roche Accu-Check Active 186 76.3±1.8 2.3 170.5±4.3 2.5 434.3±12.2 2.8
Accu-Check Inform II 485 67.2±1.4 2.1 161.6±3.0 1.9 103.2±7.1 1.8
Accu-Check Performa 722 66.5±1.8 2.8 159.5±3.4 2.1 398.8±7.6 1.9
Others
SD Biosensor SD CHECK GOLD (Meter 01GM10) 40 63.8±2.1 3.3 145.7±6.1 4.1 374.2±9.9 2.6
SD CHECK GOLD (System 01GC12)
SD CodeFree (Meter 01GM11) 123 62.4±5.3 8.4 146.8±7.8 5.3 360.6±15.0 4.2
SD CodeFree (System 01GC112) 8
SD GlucoNavii 30 59.6±2.8 4.8 134.0±6.9 5.2 339.2±21.0 6.5
SD GlucoNavii GDH (Meter 01GM30) 14 59.4±4.7 8.0 128.1±5.0 3.9 301.5±13.0 4.3
SD GlucoNavii GDH (System 01GC32) 6
SD GlucoNavii Link 0.3 (Meter 01GM12) 41 60.2±3.1 5.2 145.2±6.4 4.4 385.7±17.2 4.5
SD GlucoNavii Link 0.3 (System 01GC122)
SD GlucoNavii NFC (Meter 01GM40) 75 60.4±4.2 6.9 137.1±8.4 6.1 332.2±29.9 9.0
SD GlucoNavii NFC (System 01GC42)
Wise Meditech Wisecheck 13 38.8±0.8 1.9 112.7±1.8 1.6 337.6±5.3 1.6
Others Others 108 39.1±11.2 28.5 113.2±13.8 12.2 294.6±39.1 13.3

The instruments used were from the following companies: Abbott (Abbott Park, IL, USA), Allmedicus (Anyang, Korea), Arkray Inc. (St. Edina, MN, USA), Ascensia (Newbury, UK), GC Medis (Cheonan, Korea), Infopia (Anyang, Korea), i-SENS (Seoul, Korea), Philosys (Gunsan, Korea), Roche (Indianapolis, IN, USA), SD Biosensor (Suwon, Korea), and Wise Meditech (Anyang, Korea).

Abbreviation: SD, standard deviation; CV, coefficient of variance.

Lab Med Qual Assur 2021;43:43~55 https://doi.org/10.15263/jlmqa.2021.43.2.43
© Lab Med Qual Assur